Advagraf®, a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts

被引：30

作者：

Caillard, Sophie ^{[1
]}

Moulin, Bruno ^{[1
]}

Buron, Fanny ^{[2
]}

Mariat, Christophe ^{[3
]}

Audard, Vincent ^{[4
]}

Grimbert, Philippe ^{[4
]}

Marquet, Pierre ^{[5
]}

机构：

[1] Strasbourg Univ Hosp, Nephrol & Transplant Dept, Strasbourg, France

[2] Hop Edouard Herriot, Hosp Civils Lyon, Transplant Nephrol & Immunol Dept, Lyon, France

[3] St Etienne Univ Hosp, North Hosp, Nephrol Dialysis & Renal Transplants Dept, St Priest En Jarez, France

[4] Henri Mondor Hosp, AP HP, Nephrol & Transplant Dept, IFRNT, Creteil, France

[5] Univ Limoges, CHU Limoges, INSERM, UMR 850, Limoges, France

来源：

TRANSPLANT INTERNATIONAL | 2016年 / 29卷 / 08期

关键词：

clinical practice; extended release tacrolimus; immunosuppression; kidney transplant; therapeutic drug monitoring; TWICE-DAILY TACROLIMUS; SOLID-ORGAN TRANSPLANTATION; SINGLE-CENTER EXPERIENCE; RANDOMIZED PHASE-III; RENAL-TRANSPLANTATION; CLINICAL PHARMACOKINETICS; GRAFT FUNCTION; DAILY PROGRAF; RECIPIENTS; CONVERSION;

D O I：

10.1111/tri.12674

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The efficacy and safety of tacrolimus twice-a-day (BID) and once-a-day (QD) formulations are similar. However, the available information regarding the initiation and management of tacrolimus QD is sparse and practical information is lacking. A panel of French experts extensively reviewed the available literature on tacrolimus pharmacokinetics, clinical efficacy, and safety in kidney transplantation and, based on their own day-to-day experience, provided the practitioners with practical guidelines for the daily use and management of tacrolimus QD in de novo initiation or early conversion.

引用

页码：860 / 869

页数：10

共 34 条

[1] OSAKA Trial: A Randomized, Controlled Trial Comparing Tacrolimus QD and BD in Kidney Transplantation [J].

Albano, Laetitia ;

Banas, Bernhard ;

Klempnauer, Juergen L. ;

Glyda, Maciej ;

Viklicky, Ondrej ;

Kamar, Nassim .

TRANSPLANTATION, 2013, 96 (10) :897-903

[2] Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen [J].

Alloway, R ;

Steinberg, S ;

Khalil, K ;

Gourishankar, S ;

Miller, J ;

Norman, D ;

Hariharan, S ;

Pirsch, J ;

Matas, A ;

Zaltzman, J ;

Wisemandle, K ;

Fitzsimmons, W ;

First, MR .

TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :867-870

[3] Extended-Release Tacrolimus Therapy in De Novo Kidney Transplant Recipients: Single-Center Experience [J].

Andres, A. ;

Delgado-Arranz, M. ;

Morales, E. ;

Dipalma, T. ;

Polanco, N. ;

Gutierrez-Solis, E. ;

Morales, J. M. ;

Praga, M. ;

Gutierrez, E. ;

Gonzalez, E. .

TRANSPLANTATION PROCEEDINGS, 2010, 42 (08) :3034-3037

[4]

[Anonymous], 2010, TRANSPLANT P

[5] Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation [J].

Benkali, Khaled ;

Rostaing, Lionel ;

Premaud, Aurelie ;

Woillard, Jean-Baptiste ;

Saint-Marcoux, Franck ;

Urien, Saik ;

Kamar, Nassim ;

Marquet, Pierre ;

Rousseau, Annick .

CLINICAL PHARMACOKINETICS, 2010, 49 (10) :683-692

[6] Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review [J].

Butler, JA ;

Roderick, P ;

Mullee, M ;

Mason, JC ;

Peveler, RC .

TRANSPLANTATION, 2004, 77 (05) :769-776

[7] De Novo Kidney Transplant Recipients Need Higher Doses of Advagraf Compared With Prograf to Get Therapeutic Levels [J].

Crespo, M. ;

Mir, M. ;

Marin, M. ;

Hurtado, S. ;

Estadella, C. ;

Guri, X. ;

Rap, O. ;

Moral, R. ;

Puig, J. M. ;

Lloveras, J. .

TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) :2115-2117

[8] Reduced C0 Concentrations and Increased Dose Requirements in Renal Allograft Recipients Converted to the Novel Once-Daily Tacrolimus Formulation [J].

de Jonge, Hylke ;

Kuypers, Dirk R. ;

Verbeke, Kristin ;

Vanrenterghem, Yves .

TRANSPLANTATION, 2010, 90 (05) :523-529

[9] Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation [J].

Dew, Mary Amanda ;

DiMartini, Andrea F. ;

Dabbs, Annette De Vito ;

Myaskovsky, Larissa ;

Steel, Jennifer ;

Unruh, Mark ;

Switzer, Galen E. ;

Zomak, Rachelle ;

Kormos, Robert L. ;

Greenhouse, Joel B. .

TRANSPLANTATION, 2007, 83 (07) :858-873

[10] Modified release tacrolimus [J].

First, MR ;

Fitzsimmons, WE .

YONSEI MEDICAL JOURNAL, 2004, 45 (06) :1127-1131

← 1 2 3 4 →